CHC HEALTHCARE GROUP |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 56.4 TWD | 0.00% |
|
-1.40% | -7.69% |
| Mar. 14 | CHC Healthcare Group Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Mar. 13 | CHC Healthcare Group Proposes Dividend Distribution for the Year Ended December 31, 2023 | CI |
| Sales 2024 * | 4.34B 133M | Sales 2025 * | - | Capitalization | 9.46B 290M |
|---|---|---|---|---|---|
| Net income 2024 * | 566M 17.38M | Net income 2025 * | 717M 22.01M | EV / Sales 2024 * | 2.18 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
| P/E ratio 2024 * |
16.6
x | P/E ratio 2025 * |
13.1
x | Employees | - |
| Yield 2024 * |
4.82% | Yield 2025 * |
-
| Free-Float | 59.81% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 week | -1.40% | ||
| Current month | -6.47% | ||
| 1 month | -8.44% | ||
| 3 months | -2.93% | ||
| 6 months | -4.08% | ||
| Current year | -7.69% |
1 week
55.40
57.70
1 month
55.4061.80
Current year
55.4062.70
1 year
52.0075.60
3 years
33.0075.70
5 years
27.6575.70
10 years
27.6587.40
| Managers | Title | Age | Since |
|---|---|---|---|
Pei Lin Lee
CEO | Chief Executive Officer | - | 09-11-24 |
Yi Chun Chen
DFI | Director of Finance/CFO | - | 11-01-31 |
Ming Lun Lee
COO | Chief Operating Officer | - | 10-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Yung Shun Chuang
BRD | Director/Board Member | - | 14-06-16 |
Pei Lin Lee
CEO | Chief Executive Officer | - | 09-11-24 |
Kuei Tuan Chen
BRD | Director/Board Member | - | 12-01-05 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.05% | 0 M€ | 0.00% | - | |
| 0.00% | 34 M€ | +2.35% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-24 | 56.4 | 0.00% | 387,758 |
| 24-04-23 | 56.4 | 0.00% | 272,946 |
| 24-04-22 | 56.4 | +1.44% | 460,449 |
| 24-04-19 | 55.6 | -4.14% | 1,426,172 |
| 24-04-18 | 58 | +1.40% | 480,895 |
End-of-day quote Taiwan S.E., April 23, 2024
More quotes
CHC Healthcare Group is a Taiwan-based investment holding company. The Company primarily involves in the agent distribution of radiation oncology, neurology, medical image and nuclear medical, as well as dental and ophthalmological equipment and instrument. The Company also offers related maintenance and leasing services, components and consumable materials and specialty consulting services. The Company deals with medical instrument with brands as Elekta, PTW, GE, Ashland, Megin, Leica, Hillrom, Sony, Ellex and Wexler, among others. The Company is also involved in the operation of pharmacy.
Calendar
2024-07-29
- Q2 2024 Earnings Release (Projected)
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
56.4
TWD
Average target price
71
TWD
Spread / Average Target
+25.89%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -7.69% | 290M | |
| +16.79% | 205M | |
| +26.13% | 77.74M | |
| +18.92% | 64.83M |
- Stock Market
- Equities
- 4164 Stock
